(October 1, 2020) Live Demonstration – Understanding the Complimentary Nature of BLI, Ultrasound, and MRI for Preclinical Imaging

This was a full day of live imaging where we examined the complimentary nature of three preclinical imaging modalities – bioluminescence, high-frequency ultrasound, and MRI. We imaged the same tumor models on each of the imaging modalities; but will also had normal mouse available to look at cardiovascular function using ultrasound, and brain anatomy using MRI.

Below are the imaging modalities that were demonstrated

About the Speaker (s)

Tonya Coulthard, MSc

Team Leader, Imaging Division

Scintica, London, Ontario

Tonya Coulthard holds an MSc from the University of British Columbia in Experimental Medicine. Throughout her academic training she focused on a variety of diseases ranging from prions to chronic obstructive pulmonary disorder. In her professional career she has worked with several imaging and medical device companies; in these roles she has interacted with researchers around the world covering a very diverse range of research applications. In her present role at Scintica Instrumentation Tonya manages our Imaging Division; in this role she works in supporting our customers in understanding the products offered and how these instruments help to meet their research needs.

Katie Parkins, PhD

Product Manager, Imaging Division

Scintica, London, Ontario

Katie Parkins holds a PhD from the University of Western Ontario in Medical Biophysics. Throughout her research training she was focused on the development and application of novel molecular imaging tools to monitor and treat disease, specifically, cancer. Additionally, Katie completed a Postdoctoral Fellowship at Johns Hopkins University where she used multimodal imaging to investigate the molecular mechanisms that may determine immunotherapy response. In her present role as Preclinical Imaging Specialist at Scintica Instrumentation, Katie supports our customers in understanding the products offered and how these instruments help to meet their research needs.

Mohammedayaz Rangrez, PhD

Dr. Mohammedayaz Rangrez is an imaging scientist with a Ph.D. in preclinical research on a bilateral ovariectomy model for osteoporosis. He has a broad background in microscopy, biochemistry, physiology, and drug discovery. He was associated with the European Molecular Biology Laboratories, Heidelberg, Germany as a Technical Officer, developing e-learning courses on super-resolution microscopy. Previously, Dr. Rangrez was working as a Product Manager for in vivo microscopy at Scintica Instrumentation, with his expertise in application development and training. At present Dr. Rangrez is working as a research associate in Sunnybrook Hospital and University Health Network, Toronto, Canada.